Publisher： Karger
E-ISSN： 1423-0232|69|3|34-45
ISSN： 0030-2414
Source： Oncology, Vol.69, Iss.3, 2005-11, pp. : 34-45
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
FOLFIRINOX Bevacizumab Is a Promising Therapy for Chemorefractory Metastatic Colorectal Cancer
Oncology, Vol. 87, Iss. 3, 2014-07 ,pp. :
Access to resources
Recommend
Bevacizumab plus Oxaliplatin-Based Regimens for the Treatment of Colorectal Cancer
Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. :
Regarding ‘Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study’
Oncology, Vol. 80, Iss. 1-2, 2011-06 ,pp. :
Comment on ‘Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study’
Oncology, Vol. 80, Iss. 1-2, 2011-06 ,pp. :
Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study
Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. :